Abcalis Multiclonal Recombinant Secondary Antibodies

Wednesday, 10 August, 2022 | Supplied by: Sapphire Bioscience


Multiclonals are recombinant secondary antibodies developed by AdipoGen’s innovative partner Abcalis. They consist of defined mixtures of carefully selected individual recombinant monoclonal antibodies, recognising different epitopes on all four different subclasses of human IgG. Their respective epitope binding sites do not compete with each other, therefore amplifying signal strengths.

Multiclonals are useful for secondary antibody applications where a polyclonal antibody would traditionally be used and are able to provide the specificity and reproducibility only available from a recombinant antibody, making them a suitable alternative for diagnostic and research applications.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

HAWK Biosystems Quantifying Functions in Proteins (QF-Pro) reagent kits

HAWK Biosystems' Quantifying Functions in Proteins (QF-Pro) reagent kits contain the tailored...

Amsbio validated cytokines for organoid culture

Amsbio has launched over a range of over 30 independently developed and manufactured organoid...

Dendritics monoclonal antibodies for dendritic cell research

Dendritics' mouse and rat antibodies are logically grouped into several product families: DC...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd